Remove 2023 Remove Clinical Trials Remove Data
article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Ultimately, they concluded that the available data on pain and other outcomes was unreliable, with a high risk of bias. New clinical trials are urgently needed, they repeat in a familiar refrain. But upon analyzing the data, they found no significant relationship between CBD use and any of these outcomes.

Topical 176
article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. After six months of microdosing marijuana (2mg THC + 2mg CBD twice daily), his pain went from an 8/10 to a 3/10, and he’s back to playing golf three times a week.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

Drug company Lykos Therapeutics, which had filed the new drug application for MDMA therapy , was informed by the US Food and Drug Administration (FDA) that the data submitted was insufficient to receive approval, requesting that the company conduct an additional Phase 3 trial to further test the safety and efficacy of the drug.

article thumbnail

THC & CBD-Rich Cannabis for Fibromyalgia

Project CBD

Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinical trials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. Trials vol. 2023, doi:10.1186/s13063-023-07078-6 Kurlyandchik, Inna et al.

THC 143
article thumbnail

Cannabinoids for Tinnitus?

Project CBD

Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.

article thumbnail

Getting to Know Cannabigerol with Bonni Goldstein, MD

Project CBD

Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. CannMed: I’m glad you brought up ADHD.

article thumbnail

Feds Greenlight New Clinical Study Allowing Therapists to Legally Use MDMA

SpeedWeed

The US Food and Drug Administration (FDA) has just approved a new clinical trial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. .